Glaxosmithkline Pharmaceuticals Ltd share price logo

Glaxo Share Price

(GLAXO)

Check the latest share price of Glaxo, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹2902.2

1.84%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Glaxo Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹2,810.1
    Day's Price Range
    ₹2,930.9
  • 52 Week's Low

    52 Week's High

    ₹1,921
    52-Week Price Range
    ₹3,148
1 Month Return+ 2.14 %
3 Month Return+ 34.69 %
1 Year Return+ 44.63 %
Previous Close₹2,849.80
Open₹2,849.00
Volume1.77L
Upper Circuit-
Lower Circuit-
Market Cap₹46,605.29Cr

Glaxo Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹46,605.29 Cr

Return on Equity (ROE)

80.48

Return on capital employed (ROCE)

32.13

P/B Ratio

10.52

Dividend Yield

5.41

EPS (TTM)

100.04

Sector

Pharmaceuticals

How to invest in Glaxo

Investing in Glaxo is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Glaxo or GLAXO on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Glaxo or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Glaxo with just a few clicks!

Glaxo Valuation

Track how the P/E of Glaxo has moved over time to understand valuation trends.

Glaxo in the last 5 years

  • Overview

  • Trends

Lowest (-81.64x)

December 28, 2020

Today (47.94x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (333.07x)

September 15, 2020

LowHigh

Today’s Price to Earnings Ratio: 47.94x

Analysts Recommendation on Glaxo

Get updated buy, sell, and hold recommendations by analysts on Glaxo.

based on 5 analysts

HOLD

20.00%

Buy

60.00%

Hold

20.00%

Sell

60% of analysts recommend a 'HOLD' rating for Glaxo. Average target of ₹1434

Source: S&P Global Market Intelligence

Analysts Forecast on Glaxo

Get share price movements and forecasts by analysts on Glaxo.

Glaxo price forecast by 5 analysts

Downside of-47.88%

High

₹1575

Target

₹1434.00

Low

₹1215

Glaxo target price ₹1434, a slight downside of -47.88% compared to current price of ₹2902.2. According to 5 analysts rating.

Source: S&P Global Market Intelligence

Glaxo Financials

Get the annual and quarterly financial summary of Glaxo, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹761.66Cr (-)₹956.99Cr (↑25.65%)₹805.26Cr (↓15.85%)₹929.80Cr (↑15.47%)₹814.65Cr (↓12.38%)
Net Income₹132.25Cr (-)₹217.51Cr (↑64.47%)₹45.72Cr (↓78.98%)₹194.48Cr (↑325.37%)₹182.33Cr (↓6.25%)
Net Profit Margin17.36% (-)22.73% (↑30.93%)5.68% (↓75.01%)20.92% (↑268.31%)22.38% (↑6.98%)
Value in ₹ crore
Details2019202020212022
Total Assets₹3,933.30Cr (-)₹3,148.76Cr (↓19.95%)₹3,112.65Cr (↓1.15%)₹4,641.49Cr (↑49.12%)
Total Liabilities₹1,790.88Cr (-)₹1,308.72Cr (↓26.92%)₹1,615.53Cr (↑23.44%)₹1,963.87Cr (↑21.56%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹474.77Cr (-)₹411.18Cr (↓13.39%)₹490.97Cr (↑19.41%)₹594.87Cr (↑21.16%)₹819.79Cr (↑37.81%)

Glaxo Index Inclusions

S&P BSE Quality

₹1,740.74

0 (0%)

BSE 200

₹10,982.20

0 (0%)

BSE 500

₹34,765.79

0 (0%)

S&P BSE 150 MidCap

₹14,959.91

0 (0%)

Nifty 500

₹0.00

0 (0%)

BSE Mid-Cap

₹43,097.01

0 (0%)

BSE Healthcare

₹42,555.65

0 (0%)

Nifty LargeMidcap 250

₹15,416.05

0.1 (15.35%)

S&P BSE 250 LargeMidCap

₹10,383.27

0 (0%)

S&P BSE 400 MidSmallCap

₹11,171.57

0 (0%)

Nifty Midcap 150

₹20,009.05

0.21 (42.35%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (38.8%)

S&P BSE AllCap

₹10,471.31

0 (0%)

Glaxo Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Glaxo.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
75%
0.00
Foreign Institutions
2.28%
0.00
Mutual Funds
3.96%
0.00
Retail Investors
12.43%
0.00
Others
6.34%
0.00

Glaxo vs Peers

Compare market cap, revenue, PE, and other key metrics of Glaxo with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹46,605.29 Cr17.26%0.55NANA
BUY₹63,424.92 Cr22.06%0.55NANA
BUY₹87,426.64 Cr31.24%0.59NANA
BUY₹28,250.05 Cr30.32%0.64NANA
HOLD₹16,637.10 Cr6.43%0.57NANA

Glaxo News & Key Events

Latest news and events at one place to help you take investing decisions in Glaxo.

  • GSK Pharma Hits All-Time High on Strong Earnings - 24 Apr, 2025

    GlaxoSmithKline Pharmaceuticals saw its stock surge 10% to an all-time high of ₹3,147.45, driven by strong Q3FY25 earnings and positive market sentiment.

Insights on Glaxosmithkline Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.50% to 4.52% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.96% to 5.17% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, GLAXO stock has moved up by 43.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 55.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 75.00% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 16.2%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 13.19% to 12.69% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.05K Cr → 984.49 Cr (in ₹), with an average decrease of 6.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 252.5 Cr → 229.88 Cr (in ₹), with an average decrease of 9.0% per quarter

About Glaxo

GlaxoSmithKline Pharmaceuticals Limited is one of the leading pharmaceutical companies in India, with its subsidiary GlaxoSmithKline plc UK being one of the largest global research-based pharmaceutical and healthcare companies. The Company deals with manufacturing, distributing, and trading in pharmaceuticals and offers an extensive range of prescription medicines and vaccines across therapeutic areas like Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease, and Respiratory Diseases. Two manufacturing units in India are located at Nashik and Thane and a clinical development centre in Bangalore. Birth of this pharmaceutical company was marked in 1924 and since then there have been numerous achievements in terms of sales, market reputation, and product launches. During 1991, the Company entered into an agreement with CSIR and in the same year SmithKline Beecham became Eskayef Limited. In the year 1994, Family Products Division was sold to H J Heinz followed by a joint venture project with Eisai Pharmaceuticals in 1998 and Novartis Healthcare Pvt. Ltd. in 2015. GlaxoSmithKline Pharma has launched various products and brands like Cetzine, Seretide, Windia, Windamet, Boostrix, Infanrix, Parit, Carryec, Zimig, Carzec, Zemetril, Benitec, Zobactin, Olmesatan, Cobadex CZS, Mycamine, Prioix , Parit D, Esbanen, and Metered Dose Inhaler with Dose Counter. The Company has allotted 84,70,3017 Bonus Shares in Sep 2018 and recently invested Rs 1000 crore in the new manufacturing facility at Vemgal, Karnataka. Additionally, products like Menveo, EnteroPlus, Neosporin, Votrient, Revolade, Biopatch, Fluarix Tetra, Nucala, and Trevely Ellipta have been launched within the past 3 years with considerable success in the market. The Company is constantly making significant progress with immense success in terms of sales, reputation, and product launches.

Revenue: ₹814.65Cr as on June 2024 (Q2 24)
Net Profit: ₹182.33Cr as on June 2024 (Q2 24)
Listing date: 03 Nov, 1994
Chairperson Name: Renu S Karnad
OrganisationGlaxo
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Futures and Options

View the latest movement in Glaxo Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is Glaxosmithkline Pharmaceuticals Ltd price today?

Glaxosmithkline Pharmaceuticals Ltd share price today stands at ₹2902.2, Open: ₹2849, Previous Close: ₹2849.8, High: ₹2930.9, Low: ₹2810.1, 52 Week High: ₹3148, 52 Week Low: ₹1921.

How to Buy Glaxosmithkline Pharmaceuticals Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Glaxosmithkline Pharmaceuticals Ltd shares

What are today's traded volumes of Glaxosmithkline Pharmaceuticals Ltd?

Today's traded volume of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is 1.77L.

What is today's market capitalisation of Glaxosmithkline Pharmaceuticals Ltd?

Today's market capitalisation of Glaxosmithkline Pharmaceuticals Ltd(GLAXO) is ₹46,605.29 Cr.

What is the 52 Week High and Low Range of Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd (GLAXO)
Price
52 Week High
₹3148
52 Week Low
₹1921

How much percentage Glaxosmithkline Pharmaceuticals Ltd is down from its 52 Week High?

Glaxosmithkline Pharmaceuticals Ltd (GLAXO) share price is ₹2902.2. It is down -7.81% from its 52 Week High price of ₹3148

How much percentage Glaxosmithkline Pharmaceuticals Ltd is up from its 52 Week low?

Glaxosmithkline Pharmaceuticals Ltd (GLAXO) share price is ₹2902.2. It is up 51.08% from its 52 Week Low price of ₹1921